Dialysis For Heart Failure? FDA Panel Urges Randomized Trials First
This article was originally published in The Pink Sheet Daily
Executive Summary
No standard exists for the amount of fluid removal necessary to achieve positive outcomes for various conditions, even with diuretic drugs – the current standard of care for medical management of fluid overload.
You may also be interested in...
Devices In Drug Land: Med-Tech Firms Try To Break Into Pharma Territory
Medical device companies are targeting everything from headaches to psychiatric disorders and from digestive diseases to cardiac conditions in an effort to win over just a portion of these and other multibillion-dollar drug-dominated markets
Industry Involvement In Guidance Development Encouraged By FDA Working Group
In a report on best practices for guidance development, FDA encourages outside groups to submit their own draft guidance proposals to help make the overall process more efficient.
Industry Involvement In Guidance Development Encouraged By FDA Working Group
In a report on best practices for guidance development, FDA encourages outside groups to submit their own draft guidance proposals to help make the overall process more efficient.